Clinical and subclinical arteriosclerotic disease in octagenarians with hip fracture. A case-control study

被引:0
|
作者
Capdevila-Reniu, Aina [1 ]
Navarro-Lopez, Margarita [1 ]
Sierra-Benito, Cristina [2 ]
Sapena, Victor [3 ]
Suarez-Lombrana, Ana [2 ]
Camafort-Babkowski, Miguel [2 ]
Lopez-Soto, Alfonso [1 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Dept Internal Med, Orthogeriatr Unit, Barcelona, Spain
[2] Univ Barcelona, Hosp Clin Barcelona, Dept Internal Med, Hypertens & Vasc Risk Unit, Barcelona, Spain
[3] Hosp Clin Barcelona, IDIBAPS, Med Stat Core Facil, Barcelona, Spain
来源
MEDICINA CLINICA | 2024年 / 163卷 / 09期
关键词
Vascular risk; Hip fracture; Osteoporosis; Elderly; Healthy ageing; INTIMA-MEDIA THICKNESS; BONE-MINERAL DENSITY; CARDIOVASCULAR RISK-FACTORS; EXPERT CONSENSUS DOCUMENT; CALCIFICATION; OSTEOPOROSIS; POPULATION; STIFFNESS; PLAQUES; MEN;
D O I
10.1016/j.medcli.2024.05.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives: Evaluate clinical and subclinical arteriosclerotic disease in older patients with hip fracture compared with patients without fracture in order to increase knowledge about the relation between both diseases in older individuals. Patients and methods: Age- and sex-matched case-control study of octogenarians with and without recent hip fracture. Vascular risk factors, subclinical vascular diseases (assessed by carotid plaques, carotid intima media thickness and arterial stiffness) as well as cardiovascular diseases were analyzed. Univariate and multivariate logistic models were used to estimate odds ratios (OR) with their 95% confidence intervals (CI) to assess the association of the arteriosclerosis and hip fracture. Results: We analyzed 95 patients per group with a median age of 82 [79-87] years of whom 77.9% were female. Patients in both groups have elevated rates of vascular disease (25%) without differences between them. Patients with hip fracture had higher subclinical arteriosclerotic alterations with higher percentage of carotid plaques (OR 3.25 [1.06-9.97]) compared with the control group. Conclusions: Older patients with hip fracture had significantly higher presence of subclinical alterations but not increase on rate of cardiovascular arteriosclerotic disease compared with those without hip fracture. (c) 2024 Elsevier Espana, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:431 / 435
页数:5
相关论文
共 50 条
  • [21] Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study
    Arbouw, M. E. L.
    Movig, K. L. L.
    van Staa, T. P.
    Egberts, A. C. G.
    Souverein, P. C.
    de Vries, F.
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 (07) : 2197 - 2204
  • [22] Anticonvulsant use and fracture: a case-control study
    Chandrasekaran, Vinoomika
    Stuart, Amanda L.
    Pasco, Julie A.
    Brennan-Olsen, Sharon L.
    Berk, Michael
    Hodge, Jason M.
    Samarasinghe, Rasika M.
    Williams, Lana J.
    JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2021, 21 (03) : 422 - 428
  • [23] Factors related to successful rehabilitation after hip fracture: A case-control study
    Lieberman, D
    Fried, V
    Castel, H
    Weitzmann, S
    Lowenthal, MN
    Galinsky, D
    DISABILITY AND REHABILITATION, 1996, 18 (05) : 224 - 230
  • [24] Global burden of hip fracture: The Global Burden of Disease Study
    Feng, Jing-nan
    Zhang, Cheng-gui
    Li, Bao-hua
    Zhan, Si-yan
    Wang, Sheng-feng
    Song, Chun-li
    OSTEOPOROSIS INTERNATIONAL, 2024, 35 (01) : 41 - 52
  • [25] Relationship between bone mineral density and fragility fracture risk: a case-control study in Changsha, China
    Li, Hong-Li
    Shen, Yi
    Tan, Li-Hua
    Fu, Song-Bo
    Dai, Ru-Chun
    Yuan, Ling-Qing
    Sheng, Zhi-Feng
    Xie, Zhong-Jian
    Wu, Xian-Ping
    Liao, Er-Yuan
    Tang, Xu-Lei
    Wu, Xi-Yu
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [26] Statins and hip fracture risk in men: a population-based case-control study
    Adams, Annette L.
    Shi, Jiaxiao M.
    Reynolds, Kristi
    Hague, Reina
    Cheetham, T. Craig
    Kawatkar, Aniket A.
    Fithian, Donald C.
    Jacobsen, Steven J.
    ANNALS OF EPIDEMIOLOGY, 2015, 25 (11) : 844 - 848
  • [27] Use of thiazolidinediones and risk of hip fracture in old people in a case-control study in Taiwan
    Lin, Hsien-Feng
    Liao, Kuan-Fu
    Chang, Ching-Mei
    Lin, Cheng-Li
    Lin, Chih-Hsueh
    Lai, Shih-Wei
    MEDICINE, 2017, 96 (36)
  • [28] Severity of vertebral fracture and risk of hip fracture: a nested case–control study
    V. Puisto
    M. Heliövaara
    O. Impivaara
    T. Jalanko
    H. Kröger
    P. Knekt
    A. Aromaa
    H. Rissanen
    I. Helenius
    Osteoporosis International, 2011, 22 : 63 - 68
  • [29] Osteocytic expression of constitutive NO synthase isoforms in the femoral neck cortex:: A case-control study of intracapsular hip fracture
    Caballero-Alías, AM
    Loveridge, N
    Pitsillides, A
    Parker, M
    Kaptoge, S
    Lyon, A
    Reeve, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (02) : 268 - 273
  • [30] A population-based case-control study: proton pump inhibition and risk of hip fracture by use of bisphosphonate
    Lee, Joongyub
    Youn, KyungEun
    Choi, Nam-Kyong
    Lee, Jin-Ho
    Kang, DongYoon
    Song, Hong-Ji
    Park, Byung-Joo
    JOURNAL OF GASTROENTEROLOGY, 2013, 48 (09) : 1016 - 1022